Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gain Therapeutics (GANX) Long-Term Debt Issuances (2020)

Historic Long-Term Debt Issuances for Gain Therapeutics (GANX) over the last 1 years, with Q4 2020 value amounting to $30396.0.

  • Gain Therapeutics' Long-Term Debt Issuances changed N/A to $30396.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $738282.0, marking a year-over-year change of. This contributed to the annual value of $738282.0 for FY2020, which is N/A changed from last year.
  • As of Q4 2020, Gain Therapeutics' Long-Term Debt Issuances stood at $30396.0.
  • Over the past 5 years, Gain Therapeutics' Long-Term Debt Issuances peaked at $423288.0 during Q3 2020, and registered a low of $30396.0 during Q4 2020.